marginally insignificantP = .068
Secondary sensitivity analyses (Supplementary Table S1) including only patients with type 2 and 3 IF did not change the significant differences within groups, except for differences in IV supplementation of magnesium sulphate becoming marginally insignificant ( P = .068).